Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Other Non-Current Liabilities (2016 - 2025)

Amn Healthcare Services (AMN) has disclosed Other Non-Current Liabilities for 12 consecutive years, with $107.4 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Non-Current Liabilities fell 1.4% year-over-year to $107.4 million, compared with a TTM value of $107.4 million through Dec 2024, down 1.4%, and an annual FY2024 reading of $107.4 million, down 1.4% over the prior year.
  • Other Non-Current Liabilities was $107.4 million for Q4 2024 at Amn Healthcare Services, down from $109.7 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $110.5 million in Q1 2021 and bottomed at $22.8 million in Q1 2023.
  • Average Other Non-Current Liabilities over 5 years is $84.5 million, with a median of $107.9 million recorded in 2020.
  • The sharpest move saw Other Non-Current Liabilities surged 357.11% in 2023, then fell 1.4% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $107.9 million in 2020, then rose by 2.4% to $110.5 million in 2021, then crashed by 78.42% to $23.8 million in 2022, then skyrocketed by 357.11% to $109.0 million in 2023, then fell by 1.4% to $107.4 million in 2024.
  • Business Quant data shows Other Non-Current Liabilities for AMN at $107.4 million in Q4 2024, $109.7 million in Q2 2024, and $109.0 million in Q4 2023.